Familial Severe Non-Ischemic Dilated Cardiomyopathy With Coexisting Likely Pathogenic BAG3 and FLNC Variants: A Case Report
This case report describes a 40-year-old woman with severe familial non-ischemic dilated cardiomyopathy and a history of premature heart-failure deaths in relatives, who was found to carry coexisting likely pathogenic variants in *BAG3* and *FLNC*, highlighting the complexity of dual-gene inheritance, variable expressivity, and the critical need for cascade screening and vigilant clinical management.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart is a muscle that must beat with relentless precision, but sometimes the very instructions written in our DNA cause that muscle to weaken and stretch. When the heart's main pumping chamber becomes too large and too weak to push blood effectively, a condition known as dilated cardiomyopathy occurs. This is not a single disease with one cause; rather, it is a complex puzzle where genetics, environment, and the body's own immune system can all play a role. In many families, this condition runs in generations, striking some members in childhood and others in adulthood, often leading to heart failure. For decades, doctors have struggled to understand why some families suffer so severely while others do not, and whether a single genetic error is to blame or if multiple errors are working together to break the heart's machinery.
In a recent case report, a team of researchers in China followed the story of a forty-year-old woman whose heart suddenly began to fail, revealing a rare and complicated genetic picture. The woman arrived at the hospital after a routine cold had triggered a severe crisis. She felt tightness in her chest, struggled to breathe, and felt her heart racing. Tests showed her heart was barely functioning, pumping out only about twenty percent of the blood it should, a stark contrast to the normal range. While her heart was enlarged and leaking fluid, scans confirmed that her coronary arteries were clear, ruling out a heart attack. The pattern of damage seen on her heart scans looked like inflammation, similar to what happens when a virus attacks the heart muscle, yet her family history told a different story. Her father, her younger brother, and even a nephew had all died from heart failure, suggesting a deep-rooted genetic problem rather than a simple infection.
To find the root cause, the medical team looked inside the woman's genetic code. They discovered she carried two distinct genetic changes, each found in a different gene known to be involved in heart health. The first change was in a gene called BAG3, which acts like a quality control manager for heart muscle cells, helping them repair themselves. This specific change was a "splice-site" variant, a type of error that disrupts how the gene's instructions are read, effectively shutting down its function. The second change was in a gene called FLNC, which provides the blueprint for a protein that helps hold the heart muscle fibers together. This change was a "frameshift" mutation, a type of error that scrambles the rest of the genetic message, likely destroying the protein's ability to work.
The researchers then checked the woman's children to see how these errors were passed down. The daughter inherited the BAG3 error but did not have the FLNC error. The son had neither error. This pattern of inheritance, where the disease appears in multiple generations and affects both men and women, fits a model called autosomal dominant inheritance. However, the situation was not straightforward. The woman's severe heart failure involved both genetic errors, but only the BAG3 error was passed to her daughter, who is now at risk. The FLNC error appeared to be unique to the mother. This raised a difficult question: was the heart failure caused by the BAG3 error alone, the FLNC error alone, or a dangerous combination of both?
The medical team treated the woman with standard heart failure medications to help her heart pump more efficiently and reduce fluid buildup. Her symptoms improved, and a marker of heart stress in her blood dropped significantly, but her heart's pumping strength remained weak, hovering around twenty-five percent. She continued to have irregular heartbeats, and her heart showed signs of scarring on the scans. The researchers concluded that while the BAG3 error is the most likely driver of the family's heart disease, the presence of the FLNC error in the mother adds a layer of complexity. It is possible that the FLNC error acts as a modifier, making the heart more vulnerable, or that it is simply a coincidence in this specific patient. Without the ability to test the DNA of the deceased family members, the team could not prove for certain that both errors were necessary to cause the severe disease.
This case highlights a critical challenge in modern medicine: when a patient carries more than one genetic risk factor, it is hard to know which one is the true culprit. The researchers emphasize that finding two genetic errors does not automatically mean both are causing the disease. In this family, the BAG3 error is the clear link to the inherited pattern, while the FLNC error remains a mystery specific to the mother. The story of this woman serves as a reminder that heart disease can be a mosaic of genetic factors, and that understanding the full picture requires careful tracking of family members over time. For the daughter who inherited the BAG3 error, regular monitoring is essential, as she carries the same risk that affected her mother and grandfather. For the medical community, this report suggests that when multiple genetic errors are found, doctors should be cautious about assuming they all work together, and instead focus on the most proven genetic links while keeping a close watch on the others.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.